This document outlines the methodology used by New Leaf to calculate synthetic net returns for Sprout Healthcare Technology Portfolios. It explains the assumption of a standalone fund structure and provides a specific financial breakdown for 'Sprout IX,' detailing investments ($740M), fees ($120M), carried interest ($130M), and distributions to Limited Partners ($1,075M). The document bears a House Oversight Committee Bates stamp.
| Date | Type | From | To | Amount | Description | Actions |
|---|---|---|---|---|---|---|
| N/A | Received | Sprout IX | GPs | $130,000,000.00 | Carried interest paid out | View |
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity